Abstract
The intranasal route for administering peptides is probably one of the most neglected methods of delivery to the systemic circulation. Yet because of its high surface area available for absorption, its highly vasculized bed of mucosa and the fact that the nasal cavity appears to have very little metabolizing capacity all indicate that absorption across the nasal membranes is a reasonable proposition. The increasing importance which has been attached to peptides as new therapeutic agents is a consequence of the isolation and structural characterisation of various peptides, including the discovery of hypothalamic releasing hormones and pituitary hormones. The advantages of the naturally occuring peptide hormones as drug candidates have mainly been attributed to their potent pharmacological activity and their good biological tolerance. However, the disadvantages have been their broad pharmacological activity (which is often masked by a singular potent effect) and their relative short biological halflife (Table 1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anik, S., McRae, G., Nerenberg, C., Worden, A., Foreman, J., JiinYu, H., Kushinsky, S., Jones, R. and Vickery, B., 1984, Nasal absorption of nasarelin acetate, the decapeptide [D-Nal(2)6] LHRH, in resus monkeys. I., J. Pharm. Sci., 73: 684.
Aokif F.Y. and Crawley, J.C.W., 1976, Distribution and removal of human serum albumin — technetium 99m instilled intranasally, Br. J. Clin. Pharmacol., 3: 869.
Barltrop, D., 1963, Diabetes insipidus treated with synthetic lysine vasopressin, Lancet, i:27S.
Bond, S.W., Hardy, J.G. and Wilson C.G., 1984, Deposition and clearance of nasal sprays, Proceedings of the Second European Congress of Biopharmaceutics and Pharmacokinetics, Salamanca, Spain, 93.
Edwards, C.R.W., Kitau, M.J., Chard, T. and Besser G.M., 1973, Vasopressin analogue DDAVP in diabetes insipidus: Clinical and laboratory studies, Br. Med. J., 3: 375.
Evans, W.S., Borges, L.C., Kaiser, D.L., Vance, M.L., Sellers, R.P., Macleod R.M., Vale W., Rivier, J. and Thorner, M.O., 1983, Intranasal administration of human pancreatic tumor GH-release in normal men, J. Clin. Endocr. Metab., 57: 1081.
Fraser, R. and Scott, D.J., 1963, Nasal spray of synthetic vasopressin for the treatment of diabetes insipidus, Lancet, i:1159.
Greenwood, F.C., Hunter, W.M. and Glover, J.S., 1963, The preparation of 131I-labelled human growth hormone of high specific radioactivity, Biochem. J., 89: 114.
Hardy, J.G., Lee, S.W.S. and Wilson, C.G., 1985, intranasal drug delivery by spray and drops, J. Pharm. Pharmacol., 37: 294.
Hoover, R.T., 1971, Intranasal oxytocin in eighteen hundred patients: A study on its safety as used in a community hospital, Am. J. Obstet. Gynec., 110: 778.
Kobrinsky, N.L., Israels, E.D., Gerrard J.M., Cheang, M.S., Watson, C.M., Bishop, A.J. and Schroeder, M.L., 1984, Shortening of bleeding time by l-deamino-8-D-arginine vasopressin in various bleeding disorders Lancet, i:1145.
Lundin, S., Melin, P. and Vilhardt H., 1985, Plasma concentrations of l-deamino-8-D-arginine vasopressin after intragastric administration in the rat, Acta Endocrinol., 108: 179.
Mannucci, P.M., Canciani, M.T., Rota, L. and Donovan, B.S., 1981, Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand’s disease, Br. J. Haematol., 47: 283.
Mannucci, P.M., Ruggeri, Z.M., Pareti, F.I. and Capitanio, A., 1977, l-deamino-8-D-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand’s disease, Lancet, i:869.
Morimoto, K., Morisaka, K. and Kanada, A., 1985, Enhancement of nasal absorption of insulin and calciotonin using polyacrylic acid gel, J. Pharm. Pharmacol., 37: 134.
Nilsson, I.M., Vilhardt, H., Holmberg, L., Åstedt, B., 1982, Association between factor VIII related antigen and plasminogen activator, Acta Med. Scand., 211: 105.
Ohwaki, T., Ando, H., Watanabe, S. and Miyake, Y., 1985, Effects of Dose, pH, and Osmolarity on Nasal Absorption of Secretin in Rats, J. Pharm. Sci., 74: 550.
Richardson, D.W. and Robinson A.G., 1985, Desmopressin, Ann. Int. Med., 103: 228.
Rosen, S., Owaldsson, U., Blombäck, M., Larrieu, M., Nilsson I.M. and Vinazzer H., 1984, Evaluation of a chromogenic method for determining F VIII:C in hemophiliacs, von Willebrand patients and F VIII concentrate, Scand. J. Haematol., Suppl 40, 33: 93.
Ruggeri, Z.M., Mannucci, P.M., Jeffcoate, S.L. and Ingram, G.I.C., 1976, Immunoradiometric assay of factor VIII related antigen, with observations in 32 patients with von Willebrand’s disease, Br. J. Haematol., 33: 221.
Sandow, J. and Petri W., 1985, Intranasal administration of peptides biological activity and therapeutic efficacy, in: “Transnasal Systemic Medications,” Y.W. Chien, ed., Elsevier Science Publishers B.V., Amsterdam.
Sofroniew, M.W., Madler, M., Müller, O.H. and Scriba, P.C., 1978, A method for the consistent production of high quality antisera to small peptide hormones, Fresenius Z. Anal. Chem., 290: 163.
Vavra, I., Machova, A., Holecek, V., Cort, J.H., Zaoral, M. and Sorm, F., 1968, Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus Lancet, i:948.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Harris, A.S. (1986). Biopharmaceutical Aspects on the Intranasal Administration of Peptides. In: Davis, S.S., Illum, L., Tomlinson, E. (eds) Delivery Systems for Peptide Drugs. NATO ASI Series, vol 125. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9960-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9960-6_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9962-0
Online ISBN: 978-1-4757-9960-6
eBook Packages: Springer Book Archive